Michael Manns
Directeur/Membre du Conseil chez Vakzine Projekt Management GmbH
Profil
Michael Manns is currently a Professor at Hannover Medical School since 1991 and a Professor at Fachhochschule Mainz since 1986.
He is also a Member-Supervisory Board at Vakzine Projekt Management GmbH and Twincore, Zentrum für Experimentelle und Klinische.
Previously, he worked as a Research Associate at The Scripps Research Institute from 1987 to 1988.
Dr. Manns holds a doctorate degree from the University of Vienna, a graduate degree from Freie Universität Berlin, and undergraduate and graduate degrees from Fachhochschule Mainz.
Postes actifs de Michael Manns
| Sociétés | Poste | Début |
|---|---|---|
Vakzine Projekt Management GmbH
 Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Directeur/Membre du Conseil | 16/11/2009 |
| Hannover Medical School | Corporate Officer/Principal | 16/11/2009 |
| Fachhochschule Mainz | Corporate Officer/Principal | 16/11/2009 |
Twincore, Zentrum für Experimentelle und Klinische
 Twincore, Zentrum für Experimentelle und Klinische Miscellaneous Commercial ServicesCommercial Services Twincore, Zentrum für Experimentelle und Klinische, is a research institute based in Hannover, Germany. Twincore specializes in translational infection research, with a focus on viral infections, respiratory infections, and organ-specific immunity and metabolism research. The German company also conducts pre-clinical and clinical studies on vaccines and antiviral antibodies. Twincore has an international team of over 40 scientists from more than 20 nations, and the private company places a strong emphasis on international collaboration and exchange programs. The company has organized several symposiums and publishes research papers on various topics related to infection research. The company was founded in 2008, and the CEO is Ulrich Kalinke. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Manns
| Sociétés | Poste | Fin |
|---|---|---|
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/01/1988 |
Formation de Michael Manns
| Freie Universität Berlin | Graduate Degree |
| University of Vienna | Doctorate Degree |
| Fachhochschule Mainz | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
Twincore, Zentrum für Experimentelle und Klinische
Twincore, Zentrum für Experimentelle und Klinische Miscellaneous Commercial ServicesCommercial Services Twincore, Zentrum für Experimentelle und Klinische, is a research institute based in Hannover, Germany. Twincore specializes in translational infection research, with a focus on viral infections, respiratory infections, and organ-specific immunity and metabolism research. The German company also conducts pre-clinical and clinical studies on vaccines and antiviral antibodies. Twincore has an international team of over 40 scientists from more than 20 nations, and the private company places a strong emphasis on international collaboration and exchange programs. The company has organized several symposiums and publishes research papers on various topics related to infection research. The company was founded in 2008, and the CEO is Ulrich Kalinke. | Commercial Services |
